RCMI CLINICAL RESEARCH CENTER INFRASTRUCTURE INITATIVE

总体描述（改编自申请人摘要）：续 通过RCMI临床研究基础设施请求支持 为区域协调机制-儿童权利中心采取的举措。 具体而言，要求继续支持 增加护理和饮食工作人员，临床训练， 流行病学家/生物统计学家和HAC的扩展。 最初资助的 在德鲁申请RCMI-CRC是迈向 扩大该机构面向患者护理的研究机会。 从历史上看，RCMI-CRC在医学进步中发挥了重要作用， 从而为医学实践和医疗质量制定标准， 保健 德鲁的RCMI-CRC的存在导致了 许多临床研究人员和项目致力于 调查不成比例地影响少数群体的健康问题， 弱势群体。 此外，区域协调员管理中心的存在还导致 Drew和 加州大学洛杉矶分校医学院，海港/加州大学洛杉矶分校，南加州大学，MCW，西奈山医疗 纽约中心，JHU和杜克。 在RCMI支持的最初四年中， 以病人护理为导向的研究活动在德鲁从8个增加到 十二;公共卫生服务（PHS）;即国立卫生研究院（NIH）， 疾病控制中心（CDC）资助的临床研究（50% 增加）。 最近又资助了另外五个项目， 另有三宗PHS申请正在审查中。 这些项目代表了 德鲁的绝佳机会 不幸的是，如果没有额外的 但是，RCMI-CRC无法满足日益增长的需求。 响应 为了实现这一机构的增长，增加资金对扩大RCRII至关重要- CRC能力。 因此，本续期申请的主要目的是 扩大临床研究活动的广度， 活跃的临床研究人员的数量。

OVERALL DESCRIPTION (Adapted from the applicant's abstract): Continued support is requested through the RCMI Clinical Research Infrastructure initiative for the RCMI-CRC. Specifically, continued support is requested for the an increase in the nursing and dietary staffing, a clinically trained epidemiologist/biostatistician and expansion of the HAC. The original funded application for the RCMI-CRC at Drew was the first crucial step toward expanding patient care oriented research opportunities at the institution. Historically, RCMI-CRCs have played an influential role in medical advances, thereby setting standards for the practice of medicine and the quality of health care. The presence of a RCMI-CRC at Drew has led to an increase in the number of clinical research faculty and projects dedicated to the investigation of health issues that disproportionately affect minorities and disadvantaged populations. In addition, the presence of an RCMI-CRC has led to an increase in collaborative clinical research activities between Drew and the UCLA School of Medicine, Harbor/UCLA, USC, MCW, Mount Sinai Medical Center, N.Y., JHU, and Duke. During the initial four years of RCMI support, patient care oriented research activities have increased at Drew from eight to twelve; Public Health Service (PHS); i.e. National Institutes of Health (NIH), Centers for Disease Control (CDC)-funded clinical research studies (50 percent increase). An additional five projects have recently been funded as well as another three PHS applications under review. These projects represent an extraordinary opportunity for Drew. Unfortunately, without additional support, the RCMI-CRC is unable to handle the increased demand. In response to this institutional growth, increased funding is essential to expand RCRII- CRC capacity. As such, the broad objective of this renewal application is to expand the breadth of clinical research activities and sustain an increasing number of active clinical research faculty.